In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Start-Up Previews, November 2012

Executive Summary

This Month's Profile Group: Anti-Infective Start-Ups See Opportunity In An Epidemiological Nightmare features profiles of Arasanis, ContraFect and Fedora Pharmaceuticals. Plus these Start-Ups Across Health Care: Arrowhead Medical Technologies, Covagen, Integral Spine Solutions, Maxillent, and Vaccibody.

You may also be interested in...

Arrowhead Medical Device Technologies LLC

Arrowhead Medical Device Technologies LLC has developed the ARROW-LOK Digital Fusion System for correcting hammertoes. The one piece device consists of a stainless-steel cylindrical shaft with opposing 3-D arrowheads at each end to provide stable fixation.

Maxillent Ltd.

Maxillent Ltd. is developing an alternative to invasive sinus lift procedures for augmenting bone prior to placing dental implants. Its iRaise is a closed sinus-lift implant system that not only augments the bone, but also provides a dental implant, in one simultaneous minimally invasive procedure.

TransEnterix Names New CFO, Reports Negative Q2 Earnings Amid Challenging Times

TransEnterix hires Shameze Rampertab as its new CFO and said it expects “modest growth” in Q3 and Q4.


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts